Dunedin Public Hospital

Dunedin 9016

0 studies enrolling now · 9 studies all time

What they study most

Acute Coronary Syndrome, Atrial Fibrillation, Compensated Cirrhosis, Crohn Disease, First Line Non-Small Cell Lung Cancer, Idiopathic Pulmonary Fibrosis, Nonalcoholic Steatohepatitis, Type 1 Diabetes, Ulcerative Colitis

Studies at this site

• A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
• A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome — Completed
• Multi-center Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System and Control at Home — Completed
• Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed
• Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144 — Stopped early
• Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis — Completed
• A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease — Completed
• Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis — Completed
• Evaluate the Safety and Efficacy of FG-3019 (Pamrevlumab) in Participants With Idiopathic Pulmonary Fibrosis (IPF) — Completed